Value based pricing in Oncology - presentation at the 19th annual Cancer Progress conference in New York

MattsonJack Vice President Lee Blansett addresses the issue of Value-Based Pricing for Oncology Drugs, Including the Role of Biomarkers in Pricing - Will They Help to Set Price Points, Affect Reimbursement?

Click here for more details on the program.

No comments: